BEI Electronics to spin off medical business?
This article was originally published in Clinica
Executive Summary
BEI Electronics is considering separating its medical business from its other, unrelated activities in order to obtain new financing for the medical unit. Subject to board approval, the creation of two independent companies is set to go ahead, says Charles Crocker, chairman, president and CEO of BEI. The company's medical division, based in San Francisco, California, focuses on gynaecology and women's health.
You may also be interested in...
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.